Riga Dr Al Story
|
|
- Daniel Casey
- 5 years ago
- Views:
Transcription
1 Riga 2013 Dr Al Story
2 Plan TB control - Flawed assumptions 21 st century challenges People not Pathogens Intensified case finding - next steps
3
4 Protect the public Treat the patient
5 Infection & Inequality Infectious diseases disproportionately affect vulnerable groups in every EU Member State [1] and internationally TB especially correlates with income equality [2] Vulnerability to infectious diseases is further exacerbated by economic recession [3] 1. Semenza JC, Giesecke J (2008) Intervening on infections in inequality. American Journal of Public Health 98: Suk JMD, Buscher G, Semenza JC (2009) Wealth inequality and TB elimination in Europe. Emerging infectious diseases 15: Suhrcke M, Stuckler D, Suk JE, et al. The impact of economic crises on communicable disease transmission and control: a systematic review of the evidence. PLoS One. 2011;6(6):e Epub 2011 Jun 10.
6 Flawed assumptions 1. Sick people seek healthcare Early diagnosis 2. Patients follow medical advice Complete treatment
7 TB: Comparison case numbers UK, US and London Source: Centers for Disease Control and Health Protection Agency 2012
8 TB in London Highest rates of TB in Western Europe [1] More cases annually than Belgium, Denmark, Greece, Netherlands and Norway combined [1] 10.2% of cases are now drug resistant [2] Significant increase in MDRTB [2] [1] European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe Stockholm: European Centre for Disease Prevention and Control, [2] Any first line Drug (INH, Rif, E,Z) Tuberculosis in London: Annual report (2011 data). Health Protection Agency London Regional Epidemiology Unit, September 2012.
9 DR 2011
10 Wealth map of London
11 UK born (20%) Foreign born (80%)
12 London TB Profile study - TB Prevalence Story A et al. Thorax Aug;62(8):667-71
13 17% of all cases 30% of all infectious cases 50% of all infectious drug resistant cases Story A et al. Thorax Aug;62(8):667-71
14 Hard-to-reach (1:6)
15 Who is Hard-to-reach? Anyone whose social circumstances or lifestyle makes it difficult to:- recognise TB symptoms access health services self-administer treatment and attend regular hospital appointments
16 Key exemplars Homeless people Insecure/overcrowded - Hostels - Street Substance users In treatment or Not engaged Prisoners Current and ex Vulnerable migrants Street homeless, destitute, NRPF
17 Risk factors for drug resistance and poor treatment outcomes Not completing TB treatment - homelessness or imprisonment Any drug resistance - drug use, homelessness Multi-drug resistance - previous TB, homelessness TB in London: risk factors for drug resistance, non-adherence and poor treatment outcomes C. Anderson, S. R. Anderson, A. Story PHE National Conference In preparation
18 Drug use Homeless Prison
19 63,000 opiate and/or crack cocaine users aged between 15 and 64.
20 Homelessness - London % increase in rough sleepers (25% E. Europe) 70% increase in new rough sleepers
21 300,000 Arrests 56,000 Detained 73,000 on Bail 30% London sentenced prison releases <28 days served London 2010/11
22 Destitute migrants NRPF No right to remain Many trapped
23 TB rates highest among hardest to reach hardest to treat
24 Case detection strategies Passive Low threshold / one-stop-shop High awareness and clinical suspicion Active Contract tracing Intensified case finding
25 Who have you infected?
26 Where do you think you got TB?
27 Social Network Analysis Structured interviews improve case finding Questionnaires focus on: Drug and alcohol use Residential history Travel history Places of social aggregation Aim: to identify contacts and locations (in the context of high-risk behaviours)
28 Community Networks derived from traditional contact tracing and Social-Network Questionnaires Contact Tracing Social-Network Questionnaire Smear-pos outbreak cases Smear-neg outbreak cases Named contacts Named places of social aggregation Connect active cases to one another Connect active cases to named contacts Connect active cases to places NEJM, Vol 364( 8),pp , feb 2011.
29 TB Risk Poor health service access
30 TB Risk Poor health service access
31 Overcrowding Immunosuppression Delayed diagnosis High contact rate
32 1: Symptom + microscopy low cost & low yield 2: Symptom + microscopy + x-ray 3: X-ray + symptom + microscopy 4: X-ray + symptom + microscopy + culture - high-cost & high-yield 5: X-ray + symptom + Xpert High cost model for Xpert 6: Symptom + x-ray + Xpert Low cost model for Xpert WHO 2011
33
34 Detection (1960 s)
35 Detection (21 st C) Dutch style
36 XX/07/2005
37 XX/12/2006
38 XX/07/2008
39 53% lost prior to diagnosis
40 LO S E
41 What did we learn Very high rates of undetected active TB Flawed assumptions Suspected cases don t exist Need a package of health AND social care Leave the hospital Embrace community partners
42
43 Pan-London MDT working alongside 30 London TB services plus 223 front-line allied services in every London Borough 84 Hostels 56 Day centres 83 Drug and alcohol projects
44 Active case finding Core business Circa 10K screens per year sessions Support the most complex cases >1,472 referrals so far (34% DR - 68 MDR, 5 XDR) Locate & return to service >250 active TB cases returned so far Raise awareness Peer educators 3 rd Sector non-clinical professionals
45
46 Radiology (19 th C) Mobile Digital (21 th C)
47 Right tool for the job >75,000 CXRs 1% Query Active TB - 2% Old fibrotic lesions Case finding rate - undetected active PTB homeless people and drug users 230 per 100,000 prisoners 215 per 100,000
48 Sensitivity 82% (95% CI 67.3 to 91.8%) Specificity 99.3% (95% CI 99.1 to 99.3%) CXR PPV 0.23 Two-thirds less likely to be AFB + Story A, Aldridge RW, Abubakar I, Stagg HR, Lipman M, Watson JM, Hayward AC. Active case finding for pulmonary tuberculosis using mobile digital chest radiography: an observational study. Int J Tuberc Lung Dis Nov;16(11):1461-7
49 Impact Early detection = averted transmission Return to service >300 pulmonary cases 75% of LFU s located and returned to service 84% of cases detected complete treatment vs 83% of all cases nationally!
50 Video Observed Therapy
51 Highly cost effective
52 In major urban centres and areas of identified need commissioners should: ensure there is a programme of active casefinding using mobile digital radiography in places where homeless people and substance misusers congregate Source: NICE PH
53 Going further Diagnosis + +
54 People not Pathogens
55 PTB LTBI HCV HIV HBV
56 Force of infection The steep trajectory in seroprevalence of HCV and HBV within the first year suggests that most new infections occurred very soon after initiation of injection drug use. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health May;86(5):655-61
57
58 Next steps minutes
59 Next steps CAD 4G Teleradiology Multiplo HIV/HCV/HBV (POCT) minutes
60 Conclusions TB cannot be controlled without specific efforts to reach and treat people who are socially excluded and at high risk of disease Service users design and deliver better services
61 Conclusions Intensive cases finding strategies are essential but resource intensive - should be locally tailored and evaluated Need strong case holding service Health AND Social care
62 Conclusions Populations at high risk of TB are co-morbid impact and effectiveness of ICF likely increased by integrating BBV screening and other health / harm minimisation initiatives Integrate care pathways for TB and BBV treatment
63 and lastly What do we mean by cure?
64
65 30-year-old male crack-cocaine user presented to A&E with heamoptysis. Given oral antibiotics for presumed bronchitis and discharged home. 2 weeks later presented with heamoptysis. CXR and CT revealed a cylindrical density in the lumen of the left mainstem bronchus. 1-cm diameter glass tube with jagged edges removed by bronchoscopy. No recollection of aspiration! Kovitz KL, Mayse ML, Araujo CE, David O. Self-stenting with a crack pipe: the ultimate in 'managed care'. Respiration Jan-Feb;71(1):91.
66 TB and Crack Use 86% of crack cocaine users were smear + on diagnosis vs 36% of patients not known to use drugs Story A, Bothamley G, Hayward A. Crack cocaine and infectious tuberculosis. Emerg Infect Dis Sep;14(9):
67 Smoking crack cocaine alters alveolar macrophage function and cytokine production Crack users have thermal airways injury
68
TB control. Assumptions. Reality. Symptomatic patients seek care. Patients and professionals don t recognise symptoms
Dr Al Story TB control Assumptions Symptomatic patients seek care Patients self administer treatment Active Case Finding (ACF) is too resource intensive Patients are hard-to-reach Reality Patients and
More informationPeople not Pathogens. Al Story
People not Pathogens Al Story Plan Changing epidemiology ACF - Case management - Missed opportunities Epi transition Exposure and infection Overcrowding Homelessness Incarceration Health care access Progression
More informationPlan. A bit about TB What I do What I should do
B R E A K F A S T Plan A bit about TB What I do What I should do 575,475 583,350 810,120 667,228 755,605 7,753,555 1,068,532 2,199,500 3,442,675 1,698,957 3,255,944 2,724,347 745,514 121 39 58 113 3,440
More informationSocial determinants of infectious diseases
Social determinants of infectious diseases Informal Health Council, 5-6 July 2011, Sopot, Poland President, Commissioner, Ministers, thank you for asking me to contribute to your debate. Over the next
More informationMobile TB screening among drug users and homeless persons in Rotterdam: after the outbreak
Mobile TB screening among drug users and homeless persons in Rotterdam: after the outbreak Rob van Hest, MD, MSc, PhD, Consultant Tuberculosis Control Physician/Epidemiologist 1,2 1. Tuberculosis Control
More informationOutcomes and methods of analysis. Primary outcomes: The number of eligible clients at a hostel venue screened for active pulmonary tuberculosis by MXU
Supplementary Material V: Data extraction forms Study details Population and setting allocation to intervention/ control Outcomes and methods of analysis Results Note by review team Year: 2015 Country:
More informationIntensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite
Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Riga East Clinical hospital, Centre for tuberculosis and lung diseases. Head of outpatient department.
More informationDiagnosis of HIV and TB in the Finnish primary health care. Pekka Suomalainen M.D
Diagnosis of HIV and TB in the Finnish primary health care Inter-regional international conference Early diagnosis of HIV and associated infections, including TB, in the primary healthcare sector Petrozavodsk
More informationI n the developed world, tuberculosis (TB) is increasingly
667 TUBERCULOSIS Tuberculosis in London: the importance of homelessness, problem drug use and prison A Story, S Murad, W Roberts, M Verheyen, A C Hayward, for the London Tuberculosis Nurses Network...
More informationHCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report
HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report About HCV Action HCV Action is a network, co-ordinated by The Hepatitis C Trust, that brings together health professionals
More informationThe forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre
The forgotten group: a new HIV outbreak amongst people who inject drugs Patricia Anderson Lead CNS BBV Brownlee Centre No conflicts to declare Potted History 1981 Modern wave of drug misuse Glasgow soared
More informationNATIONAL TUBERCULOSIS PREVALENCE SURVEY 2016
NATIONAL TUBERCULOSIS PREVALENCE SURVEY 2016 Department of Health/National TB Control Program Philippine Council for Health Research and Development Foundation for the Advancement of Clinical Epidemiology,
More informationINFECTION PREVENTION AND CONTROL POLICY AND PROCEDURES Sussex Partnership NHS Foundation Trust (The Trust)
A member of: Association of UK University Hospitals INFECTION PREVENTION AND CONTROL POLICY AND PROCEDURES Sussex Partnership NHS Foundation Trust (The Trust) IPC20 VACCINATION PROGRAMME FOR STAFF AND
More informationDorset Homeless Health Needs Audit Results 2017
Dorset Homeless Health Needs Audit Results 2017 These are some of the faces of homelessness Homelessness and Health The homeless population s life expectancy is half that of the general population, equating
More informationUrban Village Medical Practice Service Review An integrated model for high quality healthcare for homeless people in Manchester
An integrated model for high quality healthcare for homeless people in Manchester Urban Village Medical Practice Urban Village Medical Practice (UVMP) is a GP practice based at Ancoats Primary Care Centre
More informationSaskatchewan HIV Strategy: Social Network Approach
Saskatchewan HIV Strategy: Social Network Approach Dr. Johnmark Opondo MHO Provincial Leadership Team (PLT) CATIE Forum: New Science, New Directions in HIV and HCV September 18, 2013 Toronto, Canada A
More informationHepatitis C Strategy. About us. What is hepatitis C?
Hepatitis C Strategy About us We support people to take control of their lives and make positive changes. For fifty years we have made a difference to people who want to change their relationship with
More informationDHMH Activities toward Implementing Requirements of Md. Code Ann., Health-General , Hepatitis C Prevention and Control within Maryland
DHMH Activities toward Implementing Requirements of Md. Code Ann., Health-General 18-1001, Hepatitis C Prevention and Control within Maryland Submitted by: Maryland Department of Health and Mental Hygiene
More informationPrimer on Tuberculosis (TB) in the United States
Primer on Tuberculosis (TB) in the United States The purpose of this primer is to provide instructors who have no prior background in TB research or clinical care with basic knowledge that they may find
More informationItem 4. Sexual Health and Blood Borne Virus Strategy Strategy for Sexual Health and Blood Borne Viruses. Background
Item 4 Strategy for Sexual Health and Blood Borne Viruses Background 1. In August 2011 the Scottish Government launched a joint Sexual Health and Blood Borne Virus Framework. This brought four policy areas
More informationTUBERCULOSIS CONTACT INVESTIGATION
TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE TUBERCULOSIS CONTACT INVESTIGATION LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe the criteria used
More informationOpportunities For Hepatitis C Modalities in Substance Use Treatment Settings
Opportunities For Hepatitis C Modalities in Substance Use Treatment Settings KATIE BURK, MPH VIRAL HEPATITIS COORDINATOR SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH 1 Webinar Outline 1. HCV Overview 2. SFDPH
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationPrimary Care and TB Control Dr Helen Booth Consultant Thoracic Physician, UCLH Clinical Lead, Integrated TB NCL-Service
Primary Care and TB Control Dr Helen Booth Consultant Thoracic Physician, UCLH Clinical Lead, Integrated TB NCL-Service North Central London TB Service TBService@nhs.net After Action Review Could we have
More information9. Screening in Special Situations
9. Screening in Special Situations Screening is the practice of identifying a condition or illness, which could benefit from early diagnosis, preventative or curative intervention. 318 Screening should
More informationClive Richardson Panteion University of Social & Political Sciences, Athens & Greek Reitox Focal Point
National income inequality and declining GDP growth rates are associated with increases in HIV diagnoses among people who inject drugs in Europe: A panel data analysis Clive Richardson Panteion University
More informationUpdate on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018
Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018 Overview Background to injecting drug use Overview of harm reduction Data on Hepatitis Summary of services provided by
More informationLTBI: Who to Test & When to Treat
LTBI: Who to Test & When to Treat TB Intensive May 10 th, 2016 David Horne, MD, MPH Harborview Medical Center University of Washington DISCLOSURES I have no disclosures or conflicts of interest to report
More informationTB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014
Sharing the Care: Working Together to Meet the Challenge of TB Presented by: Barbara Cole, RN, PHN, MSN Director, Disease Control County of Riverside Department of Public Health Curry International TB
More informationExperience with Pyrazinamide and Rifampin Regimens for Latent TB Infection
Experience with Pyrazinamide and Rifampin Regimens for Latent TB Infection Krista Powell, MD, MPH Co-Project Officer, National Surveillance for Severe Adverse Events Associated with LTBI Treatment Lead,
More informationDiagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm
Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm Kathryn Schnippel 1, Gesine Meyer-Rath 1,2, Lawrence Long 1, Wendy Stevens 3,4, Ian Sanne 1,2, and Sydney Rosen
More informationTuberculosis Procedure ICPr016. Table of Contents
Tuberculosis Procedure ICPr016 Table of Contents Tuberculosis Procedure ICPr016... 1 What is Tuberculosis?... 2 Any required definitions/explanations... 2 NHFT... 2 Tuberculosis (TB)... 3 Latent TB...
More informationContact Investigation
Tuberculosis Ann Raftery, RN, PHN, MSc GHS Learning Objectives Upon completion of this session, participants will be able to: Describe the criteria used and method for determining the infectious period
More informationGuidance on Matching Funds: Tuberculosis Finding the Missing People with TB
February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each
More informationJSNA Substance Misuse
JSNA Substance Misuse Introduction 9.1. Substance misuse causes less damage to health in absolute population terms than tobacco or alcohol. However, its association with crime and antisocial behaviour
More informationSystematic screening for active TB operational manual and tool to help prioritization
Systematic screening for active TB operational manual and tool to help prioritization Wolfheze 2015 Knut Lönnroth, Global TB Programme, 1 Strong recommendations = Should be screened in all settings 1.
More informationProgrammatic latent tuberculosis control in the European Union and candidate countries - Draft conclusions
ECDC GUIDANCE Programmatic latent tuberculosis control in the European Union and candidate countries - Draft conclusions Gerard de Vries Dominik Zenner On behalf of the ad hoc scientific panel appointed
More informationXpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work
Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection Results of Group Work DOTS expansion and enhancement Objective This group deals with the majority
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationThe National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015
The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 December 21, 2015 2 December 21, 2015 3 Can we eliminate hepatitis C? Treatments December 21, 2015 4 We Have the Roadmap
More informationSyringe Exchange Programs December 2005
Syringe Exchange Programs December 2005 In 1997, a Report to Congress concluded that needle exchange programs can be an effective component of a comprehensive strategy to prevent HIV and other blood-borne
More informationConsultation on the Draft National Strategies for Blood Borne Viruses and Sexually Transmissible Infections
Consultation on the Draft National Strategies for Blood Borne Viruses and Sexually Transmissible Infections AFAO comments on draft Third National Sexually Transmissible Infections Strategy 2014 2017 AFAO
More informationClinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis
Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis Amit S. Chitnis, MD, MPH; Pennan M. Barry, MD, MPH; Jennifer M. Flood, MD, MPH. California Tuberculosis Controllers
More informationPrinciple of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos
Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases
More informationWhat can NHS Health Scotland do to reduce health inequalities? Questions for applying the Health Inequalities Action Framework
What can NHS Health Scotland do to reduce health inequalities? Questions for applying the Health Inequalities Action Framework Introduction Definition: health inequalities are the differences in health
More informationInfectious Diseases and Sexual Health in Southwark
Chapter 7 Infectious Diseases and Sexual Health in Southwark Introduction 7.1 The JSNA 2008 did not reflect the problems of infectious diseases and this chapter redresses this gap. Infectious diseases
More informationInternational Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007
TB Along the US/Mexico Border El Paso, Texas August 22-23, 2007 International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 Barbara J Seaworth MD Medical Director Heartland National
More informationAddiction and Substance misuse pathways
Addiction and Substance misuse pathways Gordon Morse Chief Medical Officer Turning Point UK Gordon Morse statement of interests Sole employer Turning Point Some unpaid advisory work to the Hepatitis C
More informationHIV, HBV and HCV testing policy experiences and lessons learned.
HIV, HBV and HCV testing policy experiences and lessons learned. Contents HIV and viral hepatitis: distinct epidemics at different stages of evolution Epidemiology: transmission, prevalence, incidence
More informationEthiopia. Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT
Technical BRIEF Photo Credit: Challenge TB Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT Ethiopia is the second-most
More informationStrategies of drug users to avoid infection with hepatitis C
With financial support from the Drug Prevention and Information Programme of the European Union Strategies of drug users to avoid infection with hepatitis C Results from five European countries Dr. Heike
More informationTB the disease, its treatment. Tuberculosis. and prevention
TB the disease, its treatment Tuberculosis and prevention TUBERCULOSIS TB (tuberculosis) is an infectious disease that usually affects the lungs, although it can affect any part of the body. About 150
More informationThe Western Pacific Region faces significant
COMBATING COMMUNICABLE DISEASES A medical technician draws blood for HIV screening in Manila. AFP elimination of mother-to-child transmission of HIV and congenital syphilis was piloted in Malaysia and
More informationEpidemiological Methods in TB
Responding to a TB Event San Antonio, Texas April 29-May 1, 28 Epidemiological Methods in TB Lynelle Phillips, RN, MPH April 29, 28 Epidemiological Methods in TB Lynelle Phillips, RN MPH Heartland National
More informationTitle: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis.
Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis. Principal Investigator: Dick Menzies, MD Evidence base for treatment of INH resistant
More informationWhat you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014
What you need to know about diagnosing and treating TB: a preventable, fatal disease Bob Belknap M.D. Denver Public Health November 2014 The Critical First Step Consider TB in the Differential 1. Risks
More informationDrug-resistant Tuberculosis
page 1/6 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Context - Tuberculosis (TB) is an infectious disease that affects a growing number of
More informationTB the basics. (Dr) Margaret (DHA) and John (INZ)
TB the basics (Dr) Margaret (DHA) and John (INZ) Question 1 The scientist who discovered M. tuberculosis was: A: Louis Pasteur B: Robert Koch C: Jean-Antoine Villemin D: Calmette and Guerin Question 2
More informationCost-Effectiveness Analysis of TB Diagnostics David Dowdy Challenges and Future Directions
Cost-Effectiveness Analysis of TB Diagnostics David Dowdy ddowdy@jhsph.edu Challenges and Future Directions Objectives Provide an overview of cost-effectiveness analysis (CEA) as applied to TB diagnostics
More information8.0 Take Home Naloxone
8.0 Take Home Naloxone 8.1 Population characteristics For the financial year (FY) 2016/17, 721 take home naloxone (THN) kits were issued in the City of Edinburgh. Of the 323 individuals who received naloxone
More informationTUBERCULOSIS. Presented By: Public Health Madison & Dane County
TUBERCULOSIS Presented By: Public Health Madison & Dane County What is Tuberculosis? Tuberculosis, or TB, is a disease caused by a bacteria called Mycobacterium tuberculosis. The bacteria can attack any
More informationClinical guideline Published: 23 March 2011 nice.org.uk/guidance/cg120
Coexisting severe ere mental illness (psychosis) and substance misuse: assessment and management in healthcare settings Clinical guideline Published: 23 March 2011 nice.org.uk/guidance/cg120 NICE 2018.
More informationThe impact of economic recession on drug users and drug treatment
The impact of economic recession on drug users and drug treatment Designing and implementing responsive drug policies under fiscal constraints: the case of Greece Meni Malliori Assoc. Prof. of Psychiatry
More informationPromoting hepatitis B vaccination
Promoting hepatitis B vaccination Introduction Hepatitis B is a serious blood borne infection that can exacerbate hepatitis C infection, can cause serious liver damage and sometimes results in death. Hepatitis
More informationInvestigation of Contacts of Persons with Infectious Tuberculosis, 2005
1 Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 Daniel P. Dohony, MPH Division of Tuberculosis Elimination Centers for Disease Control and Prevention and Philadelphia TB Control
More informationTB Infection Control Policy. Scaling-up the implementation of collaborative TB/HIV activities in the Region of the
TB Infection Control Policy Scaling-up the implementation of collaborative TB/HIV activities in the Region of the Infection Control is aimed at minimizing the risk of TB transmission within populations
More informationGuidelines For Services Providing Injecting Equipment
Guidelines For Services Providing Injecting Equipment Best Practice Recommendations For Commissioners and Injecting Equipment Provision (IEP) Services in Scotland (Scottish Government 2010) January 2014
More informationBest Prac*ces Model for Harm Reduc*on in Bri*sh Columbia: Community Involvement
Best Prac*ces Model for Harm Reduc*on in Bri*sh Columbia: Community Involvement Authors: Despina Tzemis, Lianping Ti, Margot Kuo, Jennifer Campbell, Jane Buxton and the HRSS CommiAee Harm Reduc*on Program
More informationHealthcare for the Homeless. Dr Annie Egginton GP, Compass Health outreach at One25
Healthcare for the Homeless Dr Annie Egginton GP, Compass Health outreach at One25 A team of nurses, GPs & health link workers based at the Compass Centre, Bristol Primary healthcare and support for homeless
More informationMay 26-28, 2010, Almaty, Kazakhstan November 2011
Progress note of the recommendations of the 16 th TB/HIV Core Group Meeting Report May 26-28, 2010, Almaty, Kazakhstan November 2011 1. Structural and organizational barriers The Core Group urges Ministries
More informationECDC and Spanish Ministry of Health workshop:
ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,
More informationThe PROMs Programme in the NHS in England
The PROMs Programme in the NHS in England Veena Raleigh Senior Fellow, The King s Fund HCQI, 7 November 2013 The background Improving NHS quality a government priority since 2008 Quality defined as: effectiveness,
More informationThe Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer
The Public Health Impact of TB in the Correctional System Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer The Public Health Impact of TB in the Correctional System
More informationDelivering within the CJS
Delivering within the CJS A dedicated Substance Misuse Service CJS team will operate across the borough Bridget O Dwyer Senior Commissioning Manager Substance Misuse Service Barnet and Harrow Public Health
More informationOsaka City is the third largest city (population
Surveillance Report Strengthened tuberculosis control programme and trend of multidrug resistant tuberculosis rate in Osaka City, Japan Akira Shimouchi, a Akihiro Ohkado, a Kenji Matsumoto, b Jun Komukai,
More informationTB Contact Investigation
Ann Raftery, RN, PHN, MS Curry International TB Center Overview Contact investigation as a core TB control and elimination activity Components of TB Contact Investigation TB Control Priority Strategies.
More informationBorders Alcohol & Drugs Partnership Workforce Development and Training Directory
Borders Alcohol & Drugs Partnership Workforce Development and Training Directory 2016-2017 Unless otherwise marked all workforce development and training opportunities are available free to staff, carers
More informationIbrahim Abubakar, MBBS, MSc, PhD, FFPH
Ibrahim Abubakar, MBBS, MSc, PhD, FFPH Head of Section / Consultant Epidemiologist Tuberculosis Section HPA Centre for Infections Colindale London UK Outline TB epidemiological situation UK data collection
More informationRam Sharan Gopali (MPH) Executive Director
Ram Sharan Gopali (MPH) Executive Director Basic Facts of Nepal Nepal is a landlocked country located in the WHO Asian region at the edge of the Himalaya between India and the Peoples Republic of China
More informationHIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME
HIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME Technical considerations and case definitions for VIRAL HEPATITIS SURVEILLANCE Dr Yvan J-F Hutin Global Hepatitis Programme 01 FOUR MAIN HEPATITIS VIRUSES
More information10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose
Disclosures Updates in Tuberculosis I have nothing to disclose Chris Keh, MD Assistant Clinical Professor, Division of Infectious Diseases, UCSF TB Controller, TB Prevention and Control Program, Population
More informationSURVEY FINDINGS April 28, 2017
SURVEY FINDINGS April 28, 2017 Brenda Mungai Centre for Health Solutions-Kenya, TB ARC Outline Background Survey Rationale Methods Key Findings Conclusions Call to Action KENYA TUBERCULOSIS PREVALENCE
More informationHIV in Glasgow. Responding to an Outbreak. A special bulletin to commemorate World AIDS Day 2018
HIV in Glasgow Responding to an Outbreak A special bulletin to commemorate World AIDS Day 2018 A national resource of expertise on drug issues World AIDS Day is an opportunity for people worldwide to unite
More informationLatent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework
Latent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework 18 th Wolfheze workshops / 15 th NTP managers meeting, 31 May 02 June 2017 Dr Andrei DADU Technical officer, Joint
More informationPsychosis with coexisting substance misuse
Psychosis with coexisting substance misuse Assessment and management in adults and young people Issued: March 2011 NICE clinical guideline 120 guidance.nice.org.uk/cg120 NICE has accredited the process
More informationActivities in 2010, Priorities for 2011
European Centre for Disease Prevention and Control Activities in 2010, Priorities for 2011 Presentation to ENVI Committee by Marc Sprenger, Director ECDC 27 October 2010 Part 1: Examples of ECDC s work
More informationExperiences of site visits to Estonian low threshold service centres - improving TB case-finding and infection control
Experiences of site visits to Estonian low threshold service centres - improving TB case-finding and infection control Kristiina Salovaara / Filha EG on HIV/AIDS,Eleventh Meeting Sopot, Poland,1-2 October,
More informationHomeless and Vulnerable Persons Service
FOR PROFESSIONAL USE ONLY Revised Sept 2012 For further advice please contact: Ashton, Leigh and Wigan Division Homeless and Vulnerable Persons Service Homeless and Vulnerable Persons Service Orrell Clinic
More informationTB Control in Finland - the role of THL
TB Control in Finland - the role of THL Hanna Soini THL, Department of Health Security 1 TB in Finland 1950-2014 12000 10000 8000 6000 TB ulkomaalaiset TB yhteensä 4000 2000 0 1950 1955 1960 1965 1970
More informationINDEX CASE INFORMATION
Instructions for Completing the MDH Tuberculosis Contact Investigation Report Form Please provide as much information as possible. Each field represents information that is important to the contact investigation.
More information2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges
Outline of what it will take Tuberculosis Elimination 25: Global and Local Challenges Anne Fanning, MD November 9, 211 21 global TB trends, goals How DOTS happens at country level - an exercise New strategies
More informationPrevention and control of hepatitis B and C in the European Region of WHO
Prevention and control of hepatitis B and C in the European Region of WHO Viral Hepatitis Prevention Board Dr Nedret Emiroglu WHO Regional Office for Europe Burden of viral hepatitis in the European Region
More informationService Specification: Bristol and South Gloucestershire Specialist Substance Misuse Treatment Service January 2016
This specification is an annex to the Service Specification for the provision of Child and Adolescent Mental Health Services. It must be read along with the overarching specification which applies to all
More informationContact Investigation San Antonio, Texas January 14-15, 2013
Contact Investigation San Antonio, Texas January 14-15, 2013 Detecting and Handling a TB Outbreak Jessica Quintero, BAAS January 15, 2013 Jessica Quintero, BAAS has the following disclosures to make: No
More informationThe Hepatitis C Action Plan for Scotland: Draft Guidelines for Hepatitis C Care Networks
The Hepatitis C Action Plan for Scotland: Draft Guidelines for Hepatitis C Care Networks Royal College of Physicians of Edinburgh Friday 12 October 2007 CONTENTS 1.0 ACCOUNTABILITY AND ORGANISATION 2.0
More informationRebecca O. Sanchez, BSN., RN., MPH. has the following disclosures to make:
INFECTION CONTROL PRACTICES Rebecca O. Sanchez, RN, BSN, MPH Texas Department of State Health Services Texas Center for Infectious Disease Rebecca O. Sanchez, BSN., RN., MPH. has the following disclosures
More informationDisclosures. Current Issues and Controversies in Child and Adolescent Tuberculosis 02/24/2016. NSTC 2016 Annual Meeting
Current Issues and Controversies in Child and Adolescent Tuberculosis Jeffrey R. Starke, M.D. Professor of Pediatrics Baylor College of Medicine [With great thanks to Andrea Cruz, M.D.] Disclosures Dr.
More informationDetection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges
Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges David Karol, MD, MA Bureau of Prisons, FMC Butner Duke University Medical Center June 26, 2013 No Disclosures
More informationFrom Fix to Foil. The Dutch experience in promoting transition away from injecting drug use,
From Fix to Foil The Dutch experience in promoting transition away from injecting drug use, 1991-2009 International Harm Reduction Conference Liverpool, April 2010 John-Peter Kools Contents 1. Dutch context
More information